Haemonetics CEO Chris Simon to Unveil Growth Strategy at J.P. Morgan Healthcare Conference
Haemonetics CEO Chris Simon to present at the 44th J.P. Morgan Healthcare Conference, detailing growth, innovation and market outlook for the blood‑processing leader.
3 minutes to read









